Toffoli E - Search Results

1

Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions.

Bobkov V, Zarca AM, Van Hout A, Arimont M, Doijen J, Bialkowska M, Toffoli E, Klarenbeek A, van der Woning B, van der Vliet HJ, Van Loy T, de Haard H, Schols D, Heukers R, Smit MJ. Bobkov V, et al. Among authors: toffoli e. Biochem Pharmacol. 2018 Dec;158:413-424. doi: 10.1016/j.bcp.2018.10.014. Epub 2018 Oct 17. Biochem Pharmacol. 2018. PMID: 30342023 Free article.

2

Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.

Toffoli EC, Sheikhi A, Höppner YD, de Kok P, Yazdanpanah-Samani M, Spanholtz J, Verheul HMW, van der Vliet HJ, de Gruijl TD. Toffoli EC, et al. Cancers (Basel). 2021 Feb 9;13(4):711. doi: 10.3390/cancers13040711. Cancers (Basel). 2021. PMID: 33572396 Free PMC article. Review.

3

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study.

Toffoli EC, Sweegers MG, Bontkes HJ, Altenburg TM, Verheul HMW, van der Vliet HJ, de Gruijl TD, Buffart LM. Toffoli EC, et al. Physiol Rep. 2021 Jun;9(11):e14919. doi: 10.14814/phy2.14919. Physiol Rep. 2021. PMID: 34110712 Free PMC article. Clinical Trial.

4

Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.

Toffoli EC, Sheikhi A, Lameris R, King LA, van Vliet A, Walcheck B, Verheul HMW, Spanholtz J, Tuynman J, de Gruijl TD, van der Vliet HJ. Toffoli EC, et al. Cancers (Basel). 2021 Oct 29;13(21):5446. doi: 10.3390/cancers13215446. Cancers (Basel). 2021. PMID: 34771609 Free PMC article.

5

A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors.

King LA, Toffoli EC, Veth M, Iglesias-Guimarais V, Slot MC, Amsen D, van de Ven R, Derks S, Fransen MF, Tuynman JB, Riedl T, Roovers RC, Adang AEP, Ruben JM, Parren PWHI, de Gruijl TD, van der Vliet HJ. King LA, et al. Among authors: toffoli ec. Cancer Immunol Res. 2023 Sep 1;11(9):1237-1252. doi: 10.1158/2326-6066.CIR-23-0189. Cancer Immunol Res. 2023. PMID: 37368791

6

Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer.

Toffoli EC, van Vliet AA, Verheul HWM, van der Vliet HJ, Tuynman J, Spanholtz J, de Gruijl TD. Toffoli EC, et al. J Immunother Cancer. 2023 Dec 6;11(12):e007554. doi: 10.1136/jitc-2023-007554. J Immunother Cancer. 2023. PMID: 38056896 Free PMC article.

7

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.

van der Vorst MJDL, Neefjes ECW, Toffoli EC, Oosterling-Jansen JEW, Vergeer MR, Leemans CR, Kooistra MP, Voortman J, Verheul HMW. van der Vorst MJDL, et al. Among authors: toffoli ec. BMC Cancer. 2019 Nov 8;19(1):1066. doi: 10.1186/s12885-019-6233-9. BMC Cancer. 2019. PMID: 31703649 Free PMC article.

8

Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.

van der Vorst MJDL, Toffoli EC, Beusink M, van Linde ME, van Voorthuizen T, Brouwer S, van Zweeden AA, Vrijaldenhoven S, Berends JC, Berkhof J, Verheul HMW. van der Vorst MJDL, et al. Among authors: toffoli ec. Oncologist. 2021 Jan;26(1):e173-e181. doi: 10.1634/theoncologist.2020-0305. Epub 2020 Aug 21. Oncologist. 2021. PMID: 32735029 Free PMC article. Clinical Trial.

9

Local safety of immediate reconstruction during primary treatment of breast cancer. Direct-to-implant versus expander-based surgery.

Riggio E, Toffoli E, Tartaglione C, Marano G, Biganzoli E. Riggio E, et al. Among authors: toffoli e. J Plast Reconstr Aesthet Surg. 2019 Feb;72(2):232-242. doi: 10.1016/j.bjps.2018.10.016. Epub 2018 Nov 2. J Plast Reconstr Aesthet Surg. 2019. PMID: 30497914 Free article.

10

Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions.

Toffoli EC, van Vliet AA, Forbes C, Arns AJ, Verheul HWM, Tuynman J, van der Vliet HJ, Spanholtz J, de Gruijl TD. Toffoli EC, et al. Clin Exp Immunol. 2024 Apr 23;216(2):159-171. doi: 10.1093/cei/uxae007. Clin Exp Immunol. 2024. PMID: 38330230 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters